Basic Information
| RNALocate ID: | RLID:01001745 |
| RNA Symbol: | hsa-miR-122-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-122 |
| RNA ID: | miRBase:MIMAT0000421 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 29486652 |
| Tissue/Cell Line: | Huh-7 cells |
| Method: | Northern blot |
| Description: | Neutravidin-biotin pulldown from HuH-7 cytoplasmic extracts using in vitro transcribed and biotinylated RNA carrying four copies of the binding sites displayed in (A) or KPNB1 3′-UTR fragment of the same length. Precipitated miRNA-122 was detected by northern blot. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001744 | Cytoplasm | Huh-7 cells|Sorafenib-resistant Huh-7 cells (Huh-7-DR) | 29253196 |
| RLID:01001746 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001747 | Endoplasmic reticulum | Huh-7 cells | 26304123 |
| RLID:01001748 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001749 | Nucleus | Adjacent noncancerous tissue|HCC tissue|Huh-7 cells|Sorafenib-resistant Huh-7 cells (Huh-7-DR) | 29253196 |
| RLID:01001750 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001751 | Polysome | Human cervical cancer cell line (HeLa) | 25609084 |
| RLID:11001705 | Exosome | Breast cancer cell lines (MCF10A|MDA-MB-231) | 25621950 |
| RLID:11001706 | Exosome | B cell line (Raji) | 21505438 |
| RLID:11001707 | Exosome | Brain tissue | 23382797 |
| RLID:11001708 | Exosome | Plasma | 23663360 |
| RLID:11001709 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001710 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001711 | Microvesicle | Plasma | 23077538 |
| RLID:11001712 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000074 | Exosome | Blood|Chronic lymphocytic leukemia cells | |
| RLID-D:11000349 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-122-5p | Disease of metabolism | MNDR-E-MI-05314 |
| MNDR | hsa-miR-122-5p | Oral squamous cell carcinoma | MNDR-E-MI-05315 |
| MNDR | hsa-miR-122-5p | Lymphoma | MNDR-E-MI-05316 |
| MNDR | hsa-miR-122-5p | Cutaneous t cell lymphoma | MNDR-E-MI-05317 |
| MNDR | hsa-miR-122-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-05318 |
| MNDR | hsa-miR-122-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-05319 |
| MNDR | hsa-miR-122-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-05320 |
| MNDR | hsa-miR-122-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-05321 |
| MNDR | hsa-miR-122-5p | Her2-receptor positive breast cancer | MNDR-E-MI-05322 |
| MNDR | hsa-miR-122-5p | Breast cancer luminal a | MNDR-E-MI-05323 |
| MNDR | hsa-miR-122-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-05324 |
| MNDR | hsa-miR-122-5p | Prostate cancer | MNDR-E-MI-05325 |
| MNDR | hsa-miR-122-5p | Gastric cancer | MNDR-E-MI-05326 |
| MNDR | hsa-miR-122-5p | Alzheimer disease | MNDR-E-MI-05327 |
| MNDR | hsa-miR-122-5p | Head and neck cancer | MNDR-E-MI-05328 |
| MNDR | hsa-miR-122-5p | Primary biliary cirrhosis | MNDR-E-MI-05329 |
| MNDR | hsa-miR-122-5p | Huntington disease | MNDR-E-MI-05330 |
| MNDR | hsa-miR-122-5p | Cardiovascular disease | MNDR-E-MI-05331 |
| MNDR | hsa-miR-122-5p | Moyamoya disease | MNDR-E-MI-05332 |
| MNDR | hsa-miR-122-5p | Biliary atresia | MNDR-E-MI-05333 |
| MNDR | hsa-miR-122-5p | Parkinson disease | MNDR-E-MI-05334 |
| MNDR | hsa-miR-122-5p | Basal-like breast cancer | MNDR-E-MI-05335 |
| MNDR | hsa-miR-122-5p | Pituitary neoplasms | MNDR-E-MI-05336 |
| MNDR | hsa-miR-122-5p | Pancreatic cancer | MNDR-E-MI-05337 |
| MNDR | hsa-miR-122-5p | HCV | MNDR-E-MI-05338 |
| MNDR | hsa-miR-122-5p | Melanoma | MNDR-E-MI-05339 |
| MNDR | hsa-miR-122-5p | Hepatitis B | MNDR-E-MI-05340 |
| MNDR | hsa-miR-122-5p | Colon cancer | MNDR-E-MI-05341 |
| MNDR | hsa-miR-122-5p | Ischemic attack transient | MNDR-E-MI-05342 |
| MNDR | hsa-miR-122-5p | Familial ovarian cancer | MNDR-E-MI-05343 |
| MNDR | hsa-miR-122-5p | Kidney cancer | MNDR-E-MI-05344 |
| MNDR | hsa-miR-122-5p | Glioblastoma | MNDR-E-MI-05345 |
| MNDR | hsa-miR-122-5p | Glioma | MNDR-E-MI-05346 |
| MNDR | hsa-miR-122-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-05347 |
| MNDR | hsa-miR-122-5p | Gastrointestinal cancer | MNDR-E-MI-05348 |
| MNDR | hsa-miR-122-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-05349 |
| MNDR | hsa-miR-122-5p | Osteosarcoma | MNDR-E-MI-05350 |
| MNDR | hsa-miR-122-5p | Coronary artery disease | MNDR-E-MI-05351 |
| MNDR | hsa-miR-122-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-05352 |
| MNDR | hsa-miR-122-5p | Liver cancer | MNDR-E-MI-05353 |
| MNDR | hsa-miR-122-5p | Uterine cancer | MNDR-E-MI-05354 |
| MNDR | hsa-miR-122-5p | Cervical squamous cell carcinoma | MNDR-E-MI-05355 |
| MNDR | hsa-miR-122-5p | Pituitary adenoma | MNDR-E-MI-05356 |
| MNDR | hsa-miR-122-5p | Lung squamous cell carcinoma | MNDR-E-MI-05357 |
| MNDR | hsa-miR-122-5p | Carcinoma lung non-small-cell | MNDR-E-MI-05358 |
| MNDR | hsa-miR-122-5p | Lung adenocarcinoma | MNDR-E-MI-05359 |
| MNDR | hsa-miR-122-5p | Pancreatic adenocarcinoma | MNDR-E-MI-05360 |
| MNDR | hsa-miR-122-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-05361 |
| MNDR | hsa-miR-122-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-05362 |
| MNDR | hsa-miR-122-5p | Clear cell renal cell carcinoma | MNDR-E-MI-05363 |
| MNDR | hsa-miR-122-5p | Biliary tract cancer | MNDR-E-MI-05364 |
| MNDR | hsa-miR-122-5p | Neoplasms of the small intestine | MNDR-E-MI-05365 |
| MNDR | hsa-miR-122-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-05366 |
| MNDR | hsa-miR-122-5p | Cholangiocarcinoma | MNDR-E-MI-05367 |
| MNDR | hsa-miR-122-5p | Esophageal cancer | MNDR-E-MI-05368 |
| MNDR | hsa-miR-122-5p | Liver cirrhosis | MNDR-E-MI-05369 |
| MNDR | hsa-miR-122-5p | Synovial sarcoma | MNDR-E-MI-05370 |
| MNDR | hsa-miR-122-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-05371 |
| MNDR | hsa-miR-122-5p | Early hepatocellular carcinoma | MNDR-E-MI-05372 |
| MNDR | hsa-miR-122-5p | Familiar ovarian carcinoma | MNDR-E-MI-05373 |
| MNDR | hsa-miR-122-5p | B-cell lymphoma | MNDR-E-MI-05374 |
| MNDR | hsa-miR-122-5p | Rheumatoid arthritis | MNDR-E-MI-05375 |
| MNDR | hsa-miR-122-5p | Malignant pleural mesothelioma | MNDR-E-MI-05376 |
| MNDR | hsa-miR-122-5p | Retinoblastoma | MNDR-E-MI-05377 |
| MNDR | hsa-miR-122-5p | Osteoarthritis | MNDR-E-MI-05378 |
| MNDR | hsa-miR-122-5p | Knee osteoarthritis | MNDR-E-MI-05379 |
| MNDR | hsa-miR-122-5p | Psoriasis | MNDR-E-MI-05380 |
| MNDR | hsa-miR-122-5p | Colorectal cancer | MNDR-E-MI-05381 |
| MNDR | hsa-miR-122-5p | Nasopharynx carcinoma | MNDR-E-MI-05382 |
| MNDR | hsa-miR-122-5p | Type 2 diabetes mellitus | MNDR-E-MI-05383 |
| MNDR | hsa-miR-122-5p | Acute myocardial infarction | MNDR-E-MI-05384 |
| MNDR | hsa-miR-122-5p | Fatty liver disease | MNDR-E-MI-05385 |
| MNDR | hsa-miR-122-5p | Multiple myeloma | MNDR-E-MI-05386 |
| MNDR | hsa-miR-122-5p | Acute lymphocytic leukemia | MNDR-E-MI-05387 |
| MNDR | hsa-miR-122-5p | Infection | MNDR-E-MI-05388 |
| MNDR | hsa-miR-122-5p | Nasopharyngeal cancer | MNDR-E-MI-05389 |
| MNDR | hsa-miR-122-5p | Aids dementia complex | MNDR-E-MI-05390 |
| MNDR | hsa-miR-122-5p | Liver failure | MNDR-E-MI-05391 |
| MNDR | hsa-miR-122-5p | Acute liver failure | MNDR-E-MI-05392 |
| MNDR | hsa-miR-122-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-05393 |
| MNDR | hsa-miR-122-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-05394 |
| MNDR | hsa-miR-122-5p | Stroke lacunar | MNDR-E-MI-05395 |
| MNDR | hsa-miR-122-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-05396 |
| MNDR | hsa-miR-122-5p | Breast cancer her3+ negative | MNDR-E-MI-05397 |
| MNDR | hsa-miR-122-5p | High grade dysplastic nodule | MNDR-E-MI-05398 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AACS | Homo sapiens | RR00020644 |
TOP